Sugi Predict

Sugi Predict / Compounds / SCHEMBL20909174

SCHEMBL20909174

SCHEMBL20909174

CCc1cc(N)nc(Cl)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS2 P35228 7/20 0.39
▸ NOS3 P29474 6/20 0.39
▸ NOS1 P29475 5/20 0.38
▸ GABRP O00591 2/20 0.38
▸ GABRD O14764 2/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB1 P18505 2/20 0.38
▸ GABRG2 P18507 2/20 0.38
▸ GABRB3 P28472 2/20 0.38
▸ GABRA5 P31644 2/20 0.38
▸ GABRA3 P34903 2/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ GABRB2 P47870 2/20 0.38
▸ GABRA4 P48169 2/20 0.38
▸ GABRE P78334 2/20 0.38
▸ GABRA6 Q16445 2/20 0.38
▸ GABRG1 Q8N1C3 2/20 0.38
▸ GABRG3 Q99928 2/20 0.38
▸ GABRQ Q9UN88 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063663 0.82 NOS2 (0.42) NOS2NOS3NOS1GABRPGABRD
SCHEMBL22029038 0.80 NOS2 (0.37) NOS2NOS3NOS1GABRPGABRD
SCHEMBL11001556 0.78 SMN1; SMN2 (0.34) SMN1; SMN2KDM4EKMT2A
SCHEMBL22029121 0.76 KRAS (0.37) NOS2NOS3NOS1GABRPGABRD
SCHEMBL30826909 0.76 KRAS (0.37) NOS2NOS3NOS1GABRPGABRD
SCHEMBL3012650 0.72 NOS3 (0.39) NOS2NOS3NOS1GABRPGABRD
SCHEMBL2036773 0.72 GABRP (0.43) NOS2NOS3NOS1GABRPGABRD
SCHEMBL21287270 0.71 NOS3 (0.41) NOS2NOS3NOS1KDM4EMAPT
SCHEMBL28729594 0.70 CYP3A4 (0.36) NOS2NOS3NOS1KMT2AMAPT
SCHEMBL18620550 0.70 NOS2 (0.42) NOS2NOS3NOS1GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067636-A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. 2024-02-29 — — US disclosed
US-11702411-B2 Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors Revolution Medicines, Inc. (US) 2023-07-18 — — US disclosed
US-20200339552-A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. 2020-10-29 — — US disclosed
WO-2019075265-A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. (US) 2019-04-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200339552-A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS PTPN5, PTPN2, PTPN1 NOS2 4298/4885NOS3 4362/4885NOS1 4426/4885
US-20240067636-A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS PTPN5, PTPN2, PTPN1 NOS2 4298/4885NOS3 4362/4885NOS1 4426/4885
US-11702411-B2 Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors PTPN5, PTPN2, PTPN1 NOS2 4298/4885NOS3 4362/4885NOS1 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.